Skip to main content
Walvax Biotechnology Co.,Ltd. logo

Walvax Biotechnology Co.,Ltd. — Investor Relations & Filings

Ticker · 300142 ISIN · CNE100000WN2 LEI · 300300H82R2DIQXA8N24 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,790 across all filing types
Latest filing 2025-05-08 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300142

About Walvax Biotechnology Co.,Ltd.

https://www.walvax.com

Walvax Biotechnology Co.,Ltd. is a biopharmaceutical enterprise specializing in the research, development, production, and distribution of vaccines and other biological products. The company focuses on modern biotechnology to address public health challenges through a diverse portfolio of preventive vaccines. Key products include the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13), the bivalent human papillomavirus (HPV) vaccine, and various combination vaccines for meningitis and Haemophilus influenzae type b (Hib). Walvax operates advanced R&D platforms and manufacturing facilities that comply with international quality standards. The company is actively involved in the development of next-generation vaccine technologies, including mRNA and recombinant protein platforms, aiming to provide affordable and high-quality immunization solutions for global markets.

Recent filings

Filing Released Lang Actions
2024年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2024 Annual General Meeting Resolution Announcement" for Yunnan Watson Biotechnology Co., Ltd. It details the convening of the 2024 Annual General Meeting (AGM), including meeting attendance, voting procedures, and the results of votes on various proposals such as the 2024 Annual Report, financial reports, and profit distribution plans. The document also includes legal opinions confirming the legality of the meeting and voting process. The content is focused on announcing the official voting results and resolutions passed at the AGM, rather than presenting the full annual report or financial statements themselves. The document length is 4528 characters, which is relatively short and consistent with a voting results announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-05-08 Chinese
北京市竞天公诚（深圳）律师事务所关于公司2024年年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, attendance, and voting procedures of the 2024 Annual General Meeting (AGM) of Yunnan Watson Biotechnology Co., Ltd. It details the legality and validity of the meeting process, the qualifications of attendees, and the voting results on various agenda items including approval of the 2024 annual report and financial statements. The document does not contain the actual annual report or financial data but rather certifies the AGM procedures and voting outcomes. This type of document is typically classified as Declaration of Voting Results & Voting Rights Announcements (DVA) because it officially reports the results of shareholder votes at the AGM.
2025-05-08 Chinese
关于公司董事辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company director, Mr. Huang Zhen, from the board of directors of Yunnan Watson Biotechnology Co., Ltd. It details the resignation date, the director's shareholding, and compliance with relevant laws and regulations. There is no financial data, audit information, or report content. The document fits the category of announcements about changes in the company's board of directors or senior management.
2025-04-30 Chinese
关于召开2024年年度股东大会的提示性公告
AGM Information Classification · 95% confidence The document is a detailed announcement about the convening of the 2024 Annual General Meeting (AGM) of Yunnan Watson Biotechnology Co., Ltd. It includes information about the meeting date, voting procedures, proposals to be discussed, and registration details. It references the 2024 Annual Report and other reports to be reviewed at the meeting but does not contain the reports themselves. The document length is 4141 characters, which is relatively short and consistent with an announcement rather than a full report. The content is focused on informing shareholders about the AGM logistics and agenda, not presenting financial data or management analysis. Therefore, this document fits the category of AGM Information (AGM-R).
2025-04-29 Chinese
第五届董事会第二十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 27th meeting of the 5th Board of Directors of Yunnan Watson Biotechnology Co., Ltd. It includes details about the board meeting, voting results, and approval of the 2025 first quarter report and asset impairment provisions. The document does not contain the full quarterly report itself but announces the board's approval of it and references where the full report can be found. The document is short (1203 characters) and serves as a formal board meeting resolution announcement rather than the report itself. Therefore, it fits best under Board/Management Information (MANG) as it relates to board meeting decisions and approvals.
2025-04-25 Chinese
2025年第一季度报告披露提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (394 characters) indicating that the company has approved its 2025 first quarter report and that the full report is available on an external website. It does not contain the actual financial data or detailed report content but serves as a notice to investors to review the report elsewhere. According to the 'MENU VS MEAL' rule, such a brief notice about the report's disclosure is classified as a Report Publication Announcement (RPA), not the report itself (IR).
2025-04-25 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.